Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY

David Price, Ian D Pavord, Keith Peres Da Costa, Alvar Agustí, Gary P Anderson, Aruna T Bansal, Elisabeth H Bel, Malin Fagerås, Rod Hughes, Hiromasa Inoue, Glenda Lassi, José María Olaguibel, Alberto Papi, Marcelo Rabahi, Helen K Reddel, Adrian Rendon, Maarten Van Den Berge, Hana Müllerová
European Respiratory Journal 2021 58: PA3705; DOI: 10.1183/13993003.congress-2021.PA3705
David Price
1Observational and Pragmatic Research Institute, Singapore and Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dprice@opri.sg
Ian D Pavord
2Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith Peres Da Costa
3ZS Associates, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvar Agustí
4Respiratory Institute, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERES, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary P Anderson
5Lung Health Research Centre, Department of Pharmacology and Therapeutics, University of Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aruna T Bansal
6Acclarogen, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth H Bel
7Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malin Fagerås
8BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rod Hughes
9BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiromasa Inoue
10Department of Pulmonary Medicine, Kagoshima University, Kagoshima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenda Lassi
11BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José María Olaguibel
12Severe Asthma Unit, Complejo Hospitalario de Navarra, CIBERES, Pamplona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Papi
13Respiratory Medicine Unit, Department of Translational Medicine, Università di Ferrara, Ferrara, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo Rabahi
14Faculdade de Medicina, Universidade Federal de Goiás (UFG), Goiânia, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen K Reddel
15Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Rendon
16Universidad Autónoma de Nuevo León, Centro de Investigacion Prevencion y Tratamiento de Infecciones Respiratorias (CIPTIR), Monterrey, Nuevo León, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten Van Den Berge
17Department of Pulmonary Diseases, University Medical Center Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hana Müllerová
9BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 58 no. suppl 65
DOI 
https://doi.org/10.1183/13993003.congress-2021.PA3705

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online November 25, 2021.

Copyright & Usage 
Copyright ©the authors 2021

Author Information

  1. David Price1⇑,
  2. Ian D Pavord2,
  3. Keith Peres Da Costa3,
  4. Alvar Agustí4,
  5. Gary P Anderson5,
  6. Aruna T Bansal6,
  7. Elisabeth H Bel7,
  8. Malin Fagerås8,
  9. Rod Hughes9,
  10. Hiromasa Inoue10,
  11. Glenda Lassi11,
  12. José María Olaguibel12,
  13. Alberto Papi13,
  14. Marcelo Rabahi14,
  15. Helen K Reddel15,
  16. Adrian Rendon16,
  17. Maarten Van Den Berge17 and
  18. Hana Müllerová9
  1. 1Observational and Pragmatic Research Institute, Singapore and Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom
  2. 2Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  3. 3ZS Associates, London, United Kingdom
  4. 4Respiratory Institute, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERES, Barcelona, Spain
  5. 5Lung Health Research Centre, Department of Pharmacology and Therapeutics, University of Melbourne, Victoria, Australia
  6. 6Acclarogen, Cambridge, United Kingdom
  7. 7Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands
  8. 8BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden
  9. 9BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom
  10. 10Department of Pulmonary Medicine, Kagoshima University, Kagoshima, Japan
  11. 11BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom
  12. 12Severe Asthma Unit, Complejo Hospitalario de Navarra, CIBERES, Pamplona, Spain
  13. 13Respiratory Medicine Unit, Department of Translational Medicine, Università di Ferrara, Ferrara, Italy
  14. 14Faculdade de Medicina, Universidade Federal de Goiás (UFG), Goiânia, Brazil
  15. 15Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia
  16. 16Universidad Autónoma de Nuevo León, Centro de Investigacion Prevencion y Tratamiento de Infecciones Respiratorias (CIPTIR), Monterrey, Nuevo León, Mexico
  17. 17Department of Pulmonary Diseases, University Medical Center Groningen, Groningen, Netherlands
  1. David Price, Observational and Pragmatic Research Institute, Singapore and Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom. E-mail: dprice{at}opri.sg

Article usage

Article usage: November 2021 to December 2022

AbstractFullPdf
Nov 20216700
Dec 20218900
Jan 20224600
Feb 20223700
Mar 20225100
Apr 20224200
May 20223700
Jun 20224300
Jul 20226000
Aug 20224100
Sep 20222400
Oct 20223700
Nov 20223200
Dec 2022900

Altmetrics

Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY
David Price, Ian D Pavord, Keith Peres Da Costa, Alvar Agustí, Gary P Anderson, Aruna T Bansal, Elisabeth H Bel, Malin Fagerås, Rod Hughes, Hiromasa Inoue, Glenda Lassi, José María Olaguibel, Alberto Papi, Marcelo Rabahi, Helen K Reddel, Adrian Rendon, Maarten Van Den Berge, Hana Müllerová
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3705; DOI: 10.1183/13993003.congress-2021.PA3705

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY
David Price, Ian D Pavord, Keith Peres Da Costa, Alvar Agustí, Gary P Anderson, Aruna T Bansal, Elisabeth H Bel, Malin Fagerås, Rod Hughes, Hiromasa Inoue, Glenda Lassi, José María Olaguibel, Alberto Papi, Marcelo Rabahi, Helen K Reddel, Adrian Rendon, Maarten Van Den Berge, Hana Müllerová
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3705; DOI: 10.1183/13993003.congress-2021.PA3705
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis
  • Oxygen therapy within first 24 hours of admission in patients with COPD and risk of adverse events - an observational study
  • Heterogeneity and time course of asthma exacerbations: data from AUSTRI
Show more Monitoring airway disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society